Currency headwinds quell drug gains in Q4; says Merck KGaA Garima10 March 2019 8:59 AM ISTFRANKFURT: Germany's Merck KGaA posted a 1.3 per cent decline in adjusted core earnings in the fourth quarter as negative currency effects more than...
Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial Ruby Khatun Khatun1 Dec 2017 9:30 AM ISTFRANKFURT: Germany's Merck KGaA has suffered a setback in the development of key cancer immunotherapy Bavencio, it has failed in a trial to prolong...